Peter Machmeier | Healthcare M&A | Kroll

Peter Machmeier is a director in the Healthcare M&A Advisory practice, based in Minneapolis. Peter has over 10 years of experience advising publicly traded and privately held clients on buy- and sell-side M&A, capital raises, strategic options, valuations and other financial matters.

Peter’s healthcare experience covers a variety of areas, including aftermarket repair and maintenance services, contract development and manufacturing, medical devices and products, outsourced services and value-added distribution.

His recent engagements include advising Aterian Investment Partners on its acquisition of Allentown, LLC; the sale of SCR Medical Transportation to Beacon Mobility Corp., a portfolio company of Audax Private Equity; the sale of New Age Medical to Compass Group Equity Partners; the sale of eMindful to Wondr, a portfolio company of The Riverside Company; and the sale of Lab Products, a division of ShoreView Industries’ portfolio company Avidity Science, to Gen Cap America.

Prior to joining Kroll, Peter worked at Dougherty & Company, where he focused on capital raises, buy- and sell-side M&A, fairness opinions and valuations for middle-market clients, primarily within the healthcare industry.

Peter holds a BBA from the University of Wisconsin-Madison with a focus on finance, investments and banking. He is a FINRA Series 7, 63 and 79 registered representative.


Stay Ahead with Kroll

Corporate Finance and Restructuring

Corporate Finance and Restructuring

M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.

Healthcare Investment Banking

Healthcare Investment Banking

Healthcare expertise for middle-market M&A transactions.

Mergers and Acquisitions (M&A) Advisory

Mergers and Acquisitions (M&A) Advisory

Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.

Return to top